Literature DB >> 6424935

Isolation of urinary trypsin inhibitor-like inhibitor from human lung cancer tissue.

T Okumichi, M Nishiki, S Takasugi, N Toki, H Ezaki.   

Abstract

In the present study, a trypsin inhibitor was first extracted from lung cancer tissue and purified by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. A final yield of 20 to 60 micrograms of inhibitor with a specific activity of 2040 units/mg of protein was obtained from 1 g of original lung cancer tissue. This inhibitor inhibited trypsin strongly, plasma kallikrein weakly, and plasmin more weakly, and its molecular weight was approximately 43,000 to 45,000 as determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Its antigenicity was confirmed to be quite the same as that of human urinary trypsin inhibitor by double immunodiffusion, immunoelectrophoresis, and neutralization with anti-urinary trypsin inhibitor rabbit immunoglobulin.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6424935

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  4 in total

1.  Acid-stable protease inhibitor in chronic phase of carrageenin-induced inflammation in rats.

Authors:  M Sugiki; M Maruyama; E Yoshida; H Sumi; H Mihara
Journal:  Inflammation       Date:  1991-08       Impact factor: 4.092

2.  Synthesis and secretion of alpha 2-macroglobulin by human glioma established cell lines.

Authors:  R Businaro; C Fabrizi; L Fumagalli; G M Lauro
Journal:  Exp Brain Res       Date:  1992       Impact factor: 1.972

3.  Immunohistochemical demonstration of bikunin, a light chain of inter-alpha-trypsin inhibitor, in human brain tumors.

Authors:  E Yoshida; M Maruyama; M Sugiki; H Mihara
Journal:  Inflammation       Date:  1994-12       Impact factor: 4.092

4.  The synergistic effect of propofol and ulinastatin suppressed the viability of the human lung adenocarcinoma epithelial A549 cell line.

Authors:  Ping Li; Peipei Guo; Chunshui Lin; Murong He; Xiaoqing Zhu; Chuan Liu; Jing Tang; Wei Wang; Weidong Liang
Journal:  Oncol Lett       Date:  2018-08-08       Impact factor: 2.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.